An announcement from Century Therapeutics ( (IPSC) ) is now available.
Century Therapeutics, Inc. gears up for a strategic financial steer as Morgan Conn, Ph.D., takes the helm as Chief Financial Officer starting October 14, 2024. Bringing in a wealth of experience from his tenure at Pharvaris N.V. and PTC Therapeutics, as well as his academic background in chemistry, Dr. Conn is set to receive a comprehensive compensation package including a base salary, performance-based bonus, signing bonus, and equity awards. Dr. Conn’s appointment is fortified with an executive agreement that outlines terms of salary continuation and equity vesting in scenarios of termination with or without cause, aligning his interests with the company’s long-term success.
See more insights into IPSC stock on TipRanks’ Stock Analysis page.
